Cell and Gene Therapy and Vaccine Manufacturing Forum
The Cell and Gene Therapy and Vaccine Manufacturing Forum (CGTV Forum) was established in late 2018 in order to address the opportunity for Ireland to capitalise on the burgeoning therapeutic and commercial interest in cell and gene therapies (and more recently novel vaccines) – and in particular to replicate the success seen in attracting FDI in the recombinant protein manufacturing space over the last 2 decades. There are now over 100 members representing a variety of different stakeholders including: government agencies, national funding agencies, MNCs, SMEs, HPRA, BPCI, NTMA, VCs, academics, equipment vendors, design/engineering houses and specialist recruiters.
The Forum is currently working on addressing what we believe Ireland needs to do to ensure we capitalise on the huge commercial and therapeutic opportunity that CGT&V represent. In Q1 2021 7 working groups were established to focus on specific areas we believe should be prioritised in order to ensure success:
- Working Group 1: Development of a CGT & V manufacturing technical/capability ‘strengths-map’ for Ireland
- Working Group 2: Understanding the big challenges facing CGT & V manufacturing
- Working Group 3: Influencing Ireland investment/funding decision-making in CGT & V manufacturing
- Working Group 4: Influencing European decision-making in CGT&V manufacturing
- Working Group 5: CGT Education & Training
- Working Group 6: CGTV indigenous start-ups and SMEs
- Working Group 7: CGT Clinical Trials
Throughout 2021 these groups will generate recommendations and strategies that we hope will ultimately shape national policy and actions to ensure that the ecosystem:
- Attracts FDI in the form of CGTV manufacturing activity (with an ambition to match the success in the recombinant protein space in recent decades)
- Prioritises, supports and promotes indigenous innovation within the HEI and start-up sector
- Provides relevant education and training offerings to ensure the development of an appropriately skilled workforce
- Is an attractive location for supporting clinical trials in CGT&V
Please keep an eye on this website in the coming months which we hope to develop into a useful information portal for those interested in activities and expertise within Ireland in the CGT&V space.
For further information, please contact Prof. Niall Barron.